KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57,557 | -45.2% | 32,155 | +19.0% | 0.00% | – |
| Q1 2023 | $105,088 | +14.4% | 27,015 | 0.0% | 0.00% | – |
| Q4 2022 | $91,851 | -68.3% | 27,015 | -49.1% | 0.00% | -100.0% |
| Q3 2022 | $290,000 | +21.3% | 53,075 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $239,000 | -38.9% | 53,075 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $391,000 | +14.7% | 53,075 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $341,000 | +10.4% | 53,075 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $309,000 | -9.6% | 53,091 | +60.1% | 0.00% | 0.0% |
| Q2 2021 | $342,000 | +23.5% | 33,171 | +25.9% | 0.00% | 0.0% |
| Q1 2021 | $277,000 | -32.1% | 26,346 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $408,000 | +6.0% | 26,346 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $385,000 | -22.8% | 26,346 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $499,000 | +23.2% | 26,346 | +24.9% | 0.00% | 0.0% |
| Q1 2020 | $405,000 | +18.4% | 21,093 | +18.3% | 0.00% | 0.0% |
| Q4 2019 | $342,000 | +115.1% | 17,823 | +8.1% | 0.00% | – |
| Q3 2019 | $159,000 | +60.6% | 16,493 | 0.0% | 0.00% | – |
| Q2 2019 | $99,000 | +3.1% | 16,493 | 0.0% | 0.00% | – |
| Q1 2019 | $96,000 | -38.1% | 16,493 | 0.0% | 0.00% | – |
| Q4 2018 | $155,000 | -44.2% | 16,493 | +0.9% | 0.00% | -100.0% |
| Q3 2018 | $278,000 | 0.0% | 16,349 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $278,000 | +33.0% | 16,349 | +5.1% | 0.00% | 0.0% |
| Q1 2018 | $209,000 | +47.2% | 15,549 | +5.3% | 0.00% | – |
| Q4 2017 | $142,000 | -12.3% | 14,761 | 0.0% | 0.00% | – |
| Q3 2017 | $162,000 | +20.9% | 14,761 | 0.0% | 0.00% | – |
| Q2 2017 | $134,000 | -16.8% | 14,761 | +18.0% | 0.00% | – |
| Q1 2017 | $161,000 | +36.4% | 12,506 | 0.0% | 0.00% | – |
| Q4 2016 | $118,000 | -3.3% | 12,506 | 0.0% | 0.00% | – |
| Q3 2016 | $122,000 | +45.2% | 12,506 | 0.0% | 0.00% | – |
| Q2 2016 | $84,000 | -23.6% | 12,506 | +1.4% | 0.00% | – |
| Q1 2016 | $110,000 | -32.5% | 12,338 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $163,000 | +26.4% | 12,338 | +1.1% | 0.00% | – |
| Q3 2015 | $129,000 | -59.2% | 12,208 | +5.2% | 0.00% | -100.0% |
| Q2 2015 | $316,000 | +29.0% | 11,608 | +45.2% | 0.00% | 0.0% |
| Q1 2015 | $245,000 | -7.2% | 7,992 | +13.1% | 0.00% | 0.0% |
| Q4 2014 | $264,000 | +9.1% | 7,066 | +2.0% | 0.00% | 0.0% |
| Q3 2014 | $242,000 | – | 6,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |